Skip to content

UFP Technologies UFPT Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$40.68M+0.3%
Baxter International logo
Baxter InternationalBAX
$213M+210%
Medline, Inc.
 logo
Medline, Inc. MDLN
$412M-39.6%
Solventum logo
SolventumSOLV
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's cash provided by (used in) operating activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's cash provided by (used in) operating activity, including discontinued operation?
UFP Technologies (UFPT) reported cash provided by (used in) operating activity, including discontinued operation of $3.2M in Q1 2026.
How has UFP Technologies's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
UFP Technologies's cash provided by (used in) operating activity, including discontinued operation decreased by 76.8% year-over-year, from $13.81M to $3.2M.
What is the long-term trend for UFP Technologies's cash provided by (used in) operating activity, including discontinued operation?
Over 4 years (2021 to 2025), UFP Technologies's cash provided by (used in) operating activity, including discontinued operation has grown at a 59.2% compound annual growth rate (CAGR), from $14.29M to $91.91M.
What does cash provided by (used in) operating activity, including discontinued operation mean?
Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.